Skip to main content
. 2021 Aug 31;7(2):533–547. doi: 10.1007/s41030-021-00168-3

Table 2.

Clinical recommendations summary

FAS population (n = 96)
Clinical recommendations made, n 36
Patients given a clinical recommendation, n (%) 20 (20.8)
Number of clinical recommendations made per patienta, mean (SD) 1.8 (1.7)
Patients with a symptom alertb, n (%) 87 (90.6)
 Elevated symptom score reportsb, n (%) 2142 (17.4)c
Patient treatment days with an elevated symptom scoreb,d, (%) 13.1
Clinical recommendation (n = 36)e, n (%)
 Transfer toll-free call 4 (11.1)
 Connected toll-free call 9 (25.0)
 Did not use toll-free number 23 (63.9)
Time to clinical recommendation (n = 34)f, (h)
 Median (IQR) 7.1 (4.0–29.9)
Time to clinical recommendation by toll-free number (n = 11)f, (h)
 Median (IQR) 2.1 (0.0–7.2)
Time to clinical recommendation by other form of contact (n = 23)f, (h)
 Median (IQR) 19.6 (4.5–45.3)

FAS full analysis set, IQR interquartile range, SD standard deviation

aOnly calculated for patients given a clinical recommendation

bA daily symptom score is considered elevated (symptom alert) when a patient’s current daily symptom score is ≥ 1.0 point(s) higher compared with their baseline symptom score

cOut of a total of 12,342 symptom reports

dPatient days with an elevated symptom score = (number of elevated symptom score reports/sum of patients’ time on treatment) × 100

eClinical recommendations were received by 20 patients

fTime to clinical recommendation is calculated only for 34 clinical recommendations that were documented in the electronic data capture; 2 calls were not captured in the electronic data capture